A response to the letter to the editor on "Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study"

J Oncol Pharm Pract. 2018 Sep;24(6):478-479. doi: 10.1177/1078155218782614. Epub 2018 Jun 20.

Authors

Denise Yeo¹, Ihtimam Hossain², Soon Thye Lim³, Mohamad Farid³, Miriam Tao³, Richard Quek³, Tiffany Tang³, Alexandre Chan^{1

4}

Affiliations

¹ 1 Department of Pharmacy, National University of Singapore, Singapore.
² 2 Department of Pharmacy, Singapore General Hospital, Singapore.
³ 3 Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
⁴ 4 Department of Pharmacy, National Cancer Centre Singapore, Singapore.

PMID: 29925294
DOI: 10.1177/1078155218782614

No abstract available

Publication types

Comment

MeSH terms

Hepatitis B*
Humans
Lymphoma*
Rituximab

Substances

Rituximab